SRPT LongSarepta Therapeutics
Focused on the development of precision genetic medicines to treat rare neuromuscular
and central nervous system diseases
investorrelations.sarepta.com
Major leader in treatment
- Duchenne muscular dystrophy (Duchenne) and limb-girdle muscular dystrophies (LGMDs)
- Explore pe
24,571.429
0.001 BRL
1.27 B BRL
10.25 B BRL
About Sarepta Therapeutics, Inc.
Sector
Industry
CEO
Douglas S. Ingram
Website
Headquarters
Cambridge
Founded
1980
ISIN
BRS1RPBDR005
FIGI
BBG00XV42L87
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
SRPT Sarepta Therapeutics Options Ahead of EarningsAnalyzing the options chain and the chart patterns of SRPT Sarepta Therapeuticsprior to the earnings report this week,
I would consider purchasing the 120usd strike price Calls with
an expiration date of 2025-8-15,
for a premium of approximately $9.30.
If these options prove to be profitable prior t
SRPT Sarepta Therapeutics Potential Buyout SoonIf you haven`t bought SRPT here:
Then you need to know that there is a Massive catalyst coming!
Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November.
This week institutions bought calls worth more than $10Mil that SRPT
SRPT strong supportSRPT is at a very strong support at the moment and entries can be made now if fundamentals of the company are strong
Entry @ CMP or 107 to 100
SL @ 97
TP 1 @ 120
TP 2 @ 132
This is when we are expecting that it will bounce back up from the strong support of 105
104-106 range (Strong Suppor
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SRPT5657414
Sarepta Therapeutics, Inc. 1.25% 15-SEP-2027Yield to maturity
3.18%
Maturity date
Sep 15, 2027
See all S1RP34 bonds
Curated watchlists where S1RP34 is featured.